Package 76420-020-30

{"route": ["ORAL"], "spl_id": "a7b785f9-4f75-92ed-e053-2995a90a9fa5", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310431"], "spl_set_id": ["45039bba-7a96-450c-95be-83a3aa4fcbd2"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "240 CAPSULE in 1 BOTTLE (76420-020-24)", "package_ndc": "76420-020-24", "marketing_start_date": "20200610"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (76420-020-30)", "package_ndc": "76420-020-30", "marketing_start_date": "20200610"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (76420-020-60)", "package_ndc": "76420-020-60", "marketing_start_date": "20200610"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (76420-020-90)", "package_ndc": "76420-020-90", "marketing_start_date": "20200610"}], "brand_name": "GABAPENTIN", "product_id": "76420-020_a7b785f9-4f75-92ed-e053-2995a90a9fa5", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "76420-020", "generic_name": "GABAPENTIN", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "300 mg/1"}], "application_number": "ANDA090705", "marketing_category": "ANDA", "marketing_start_date": "20171205", "listing_expiration_date": "20261231"}